Stock Scorecard



Stock Summary for Medifast Inc (MED)

Total Score

19 out of 29

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for MED

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for MED

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for MED

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for MED

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Financial Details for MED

Company Overview

Company Name Medifast Inc
Country USA
Description Medifast, Inc. manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutrition products in the United States and Asia-Pacific. The company is headquartered in Baltimore, Maryland.
Sector Name MANUFACTURING
Industry Name MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS
Most Recent Quarter 9/30/2022
Next Earnings Date 2/21/2023

Stock Price History

Last Day Price 121.13
Last Day Volume 0
Average Daily Volume 157,045
52-Week High 214.96
52-Week Low 96.00
Last Price to 52 Week Low 26.18 %

Valuation Measures

Trailing PE 9.17
Industry PE 21.41
Sector PE 65.34
5-Year Average PE 16.96
Free Cash Flow Ratio 18.99
Industry Free Cash Flow Ratio 40.72
Sector Free Cash Flow Ratio 39.05
Book Value Per Share Most Recent Quarter 13.85
Price to Book Ratio 8.72
Industry Price to Book Ratio 6.84
Sector Price to Book Ratio 6.98
Price to Sales Ratio Twelve Trailing Months 0.81
Industry Price to Sales Ratio Twelve Trailing Months 2.21
Sector Price to Sales Ratio Twelve Trailing Months 3.97

Share Statistics

Total Shares Outstanding 10,927,000
Market Capitalization 1,323,587,510
Institutional Ownership 87.57 %

Dividends

Ex-Dividend Date 9/19/2022
Last Dividend Amount 1.64
Current Dividend Amount 1.64
Dividend Aristocrat? False
Forward Annual Dividend Rate 5.68
Forward Annual Dividend Yield 2.65 %
Trailing Annual Dividend Rate 6.34
Trailing Annual Dividend Yield 5.44 %
5-Year Average Dividend Yield 0.00 %
5-Year Dividend Payments Count 21
Dividend Payout Ratio 55.20 %

Income Statement

Quarterly Earnings Growth YOY -8.10 %
Annual Earnings Growth 59.47 %
Reported EPS Past Year 10.28
Reported EPS Prior Year 13.89
Net Income Twelve Trailing Months 151,072,000
Net Income Past Year 164,031,000
Net Income Prior Year 102,859,000
Quarterly Revenue Growth YOY -5.60 %
5-Year Revenue Growth 49.99 %

Balance Sheet

Total Cash Per Share 6.38
Total Cash Most Recent Quarter 69,710,000
Total Cash Past Year 109,544,000
Total Cash Prior Year 174,475,000
Net Cash Position Most Recent Quarter 42,710,000
Net Cash Position Past Year 109,544,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 27,000,000
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 0.85
Current Ratio Most Recent Quarter 1.49
Total Stockholder Equity Past Year 202,474,000
Total Stockholder Equity Prior Year 157,246,000
Total Stockholder Equity Most Recent Quarter 150,522,000

Options

Put/Call Ratio 1.04
Has Options Options Chain
Liquidity Rating None

Technical Analysis

MACD 2.21
MACD Signal 1.16
20-Day Bollinger Lower Band 172.99
20-Day Bollinger Middle Band 184.04
20-Day Bollinger Upper Band 195.08
Beta 1.20
RSI 63.17
50-Day SMA 159.22
200-Day SMA 154.08

System

Modified 12/3/2022 6:44:00 PM